20/20 Biolabs
(NASDAQ) AIDX
20/20 Biolabs Financials at a Glance
Market Cap
$18.12M
Revenue (TTM)
$1.65M
Net Income (TTM)
$5.66M
EPS (TTM)
$0.00
P/E Ratio
3.77
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$1.70
Volume
466
Open
$1.73
Price
$1.70
Volume
466
Open
$1.73
Previous Close
$1.70
Daily Range
$1.70 - $1.73
52-Week Range
$1.51 - $50.00
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$1.70
Volume
466
Open
$1.73
Previous Close
$1.70
Daily Range
$1.70 - $1.73
52-Week Range
$1.51 - $50.00
AIDX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 20/20 Biolabs
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
14
CEO
Jonathan Cohen
Website
2020biolabs.comHeadquarters
Gaithersburg, MD 20877, US
AIDX Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
-0%
Return on Assets
-0%
Earnings Yield
26.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.12M
Shares Outstanding
10.44M
Volume
466
Short Interest
0.00%
Avg. Volume
327.62K
Financials (TTM)
Gross Profit
$604.54M
Operating Income
$3.33B
EBITDA
$3.33B
Operating Cash Flow
$1.92B
Capital Expenditure
$0.00
Free Cash Flow
$1.92B
Cash & ST Invst.
$1.03B
Total Debt
$1.28B
20/20 Biolabs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$417.98K
-0.3%
Gross Profit
$145.07K
+7703.4%
Gross Margin
34.71%
N/A
Market Cap
$18.12M
N/A
Market Cap/Employee
$1.39M
N/A
Employees
13
N/A
Net Income
$825.54K
+58.6%
EBITDA
$780.95K
+56.2%
Quarterly Fundamentals
Net Cash
$258.04M
-5035.2%
Accounts Receivable
$199.95M
+32217.3%
Inventory
$116.22M
+114767.3%
Long Term Debt
$1.11B
+51712.7%
Short Term Debt
$175.95M
+93918.9%
Return on Assets
-0.05%
N/A
Return on Invested Capital
-0.12%
N/A
Free Cash Flow
$536.45K
N/A
Operating Cash Flow
$536.45K
N/A